NCT01634919View on ClinicalTrials.gov

Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated with Peginterferon Alpha-2a and Ribavirin

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 17, 2017

Study Completion Date

February 9, 2018

Conditions
Chronic Hepatitis C
Interventions
DEVICE

chronic hepatitis C

acoustic radiation force impulse ultrasonography

Trial Locations (2)

156-707

Seoul Metropolitan Government Boramae Medical Center, Seoul

SMG-SNU Boramae Medical Center, Seoul

All Listed Sponsors
lead

Seoul National University Boramae Hospital

OTHER

NCT01634919 - Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated with Peginterferon Alpha-2a and Ribavirin | Biotech Hunter | Biotech Hunter